Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-24-006925

CVP, Chief Financial Officer sold 5,625 shares at an average $87.51 ($492,258)

  • CVP, Chief Financial Officer acquired 5,625 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ullem Scott B. · CVP, Chief Financial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-20 Exercise or conversion : show line 1 in the form 10b5-1 +5,625 $45.28 $254,681 36,186 D
2024-06-20 Sale : show line 2 in the form 10b5-1 −400 $88.11 $35,245 35,786 D
2024-06-20 Sale : show line 3 in the form 10b5-1 −5,225 $87.47 $457,013 30,561 D
Open-market sales · 5,625 sh · avg $87.51 · $492,258

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-20 Exercise or conversion : show line 4 in the form 10b5-1 Employee Stock Option (Right to Acquire) −5,625 56,250 D
Loading xslF345X05/doc4.xml…